Literature DB >> 2171700

Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.

E S Barnathan1, A Kuo, K Karikó, L Rosenfeld, S C Murray, N Behrendt, E Rønne, D Weiner, J Henkin, D B Cines.   

Abstract

Human umbilical vein endothelial cells in culture (HUVEC) express receptors for urokinase-type plasminogen activators (u-PA). The immunochemical nature of this receptor and its relationship to u-PA receptors expressed by other cell types is unknown. Cross-linking active site-blocked u-PA to HUVEC lead to an increase in its apparent molecular mass by approximately 40 Kd. The predominant u-PA binding protein isolated from whole cell detergent extracts migrated with a molecular mass of approximately 36 Kd using affinity chromatography. In contrast, when only cell surface proteins were radiolabeled before extraction, the predominant labeled u-PA binding protein isolated migrated with a molecular mass of approximately 46 Kd. Several pieces of evidence suggested that the difference in molecular mass between these two u-PA binding proteins resulted from glycosylation of a single receptor protein. First, a polyclonal antibody against u-PA receptor isolated from phorbol myristate acetate (PMA) stimulated U-937 cells reacted with both the 36- and 46-Kd proteins on Western blotting. Second, the size of the unmodified receptor was estimated by amplifying a full-length cDNA for u-PA receptor from an endothelial cell cDNA library using the polymerase chain reaction (PCR) and oligonucleotide primers corresponding to the DNA sequence of the receptor cloned from transformed human fibroblasts (Roldan et al, EMBO J 9:467, 1990). The size of the cDNA (approximately 1,054 base pairs, bp) and the presence of a single 1.4-kilobase (Kb) mRNA transcript on Northern blot analysis predict an unglycosylated receptor protein of approximately 35 Kd. Third, synthesis of 35S-labeled 46-Kd cell surface receptor protein was inhibited when the cells were grown in the presence of tunicamycin, while the synthesis of the 36-Kd species was unaffected. Moreover, the apparent molecular mass of purified surface-labeled receptor (approximately 46 Kd) was reduced by N-glycanase. These studies suggest that the u-PA receptor on the surface of HUVEC is a glycoprotein derived from a protein of approximately 35 Kd which is similar immunologically to u-PA receptors on other cell types.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171700

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

2.  Dependence of Human Vascular Cell Surface Proteolysis on Expression of the Urokinase Receptor.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.

Authors:  Sergei Zaitsev; Dirk Spitzer; Juan-Carlos Murciano; Bi-Sen Ding; Samira Tliba; M Anna Kowalska; Oscar A Marcos-Contreras; Alice Kuo; Victoria Stepanova; John P Atkinson; Mortimer Poncz; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

Review 4.  Evaluation of thrombolytic agents.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.

Authors:  W Hollas; E Soravia; A Mazar; J Henkin; F Blasi; D Boyd
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

6.  Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.

Authors:  H K Lau; M Kim; J Koo; B Chiu; D Murray
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

7.  Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.

Authors:  Inder Sehgal; Timothy P Foster; Joseph Francis
Journal:  Cancer Cell Int       Date:  2006-08-23       Impact factor: 5.722

8.  Upregulation of urokinase receptor expression on migrating endothelial cells.

Authors:  M S Pepper; A P Sappino; R Stöcklin; R Montesano; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

9.  A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.

Authors:  Mohammad Hasanuzzaman; Robert Kutner; Siamak Agha-Mohammadi; Jakob Reiser; Inder Sehgal
Journal:  Mol Cancer       Date:  2007-05-17       Impact factor: 27.401

10.  Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.

Authors:  P Koolwijk; M G van Erck; W J de Vree; M A Vermeer; H A Weich; R Hanemaaijer; V W van Hinsbergh
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.